Critics will argue that double-blind placebo-controlled trials provide more reliable information than real-world clinical ...

From capsules, gummies and other edibles, to oils and lotions, CBD products have become increasingly popular in the United ...

The FDA approves SIR-Spheres Y-90 microspheres for treating unresectable hepatocellular carcinoma, showcasing impressive ...

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public health. For this article, she interviewed dozens of people who have worked ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

The drug only prevents HIV transmission – it doesn’t block other sexually transmitted diseases. Global efforts at ending the HIV pandemic by 2030 have stalled.

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking studies, Gilead Sciences’ shot nearly eliminated new infections in people ...

The drug only prevents HIV transmission – it doesn’t block other sexually transmitted diseases. Global efforts at ending the HIV pandemic by 2030 have stalled.